Canary Global Inc. Submits a Revolutionary 2-minute, 98% Sensitivity, Digital COVID-19 Saliva Test to the FDA
Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants Designed for home, business and mass-screening use, the digital and connected platform enables user to save and store results for future reference New York, NY (February 8, 2021) – Med tech company Canary Global Inc. has developed […]
Canary Global Inc develops world first point-of-care and real-time COVID-19 variant test capable of identifying origins of virus variants on new Pelican COVID-19 platform
CANARY GLOBAL INC.’s PELICAN DIGIGENE™ PLATFORM, WORLD’S FIRST POINT OF CARE, REAL-TIME COVID-19 MUTANT IDENTIFICATION TEST COVID-19 test manufacturer continues real-time tracking variants at the point-of-care Company is committed to working with governments to reduce variant spread New York, USA – Canary Global Inc. has developed the world’s first COVID-19 rapid diagnostic point-of-care variant test, […]
Canary’s 2-minute, 98% Sensitivity, Digital COVID-19 Saliva Test Achieves CE Mark with further R&D underway.
Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants Designed for point-of-care (POC) diagnosis, ease of use and rapid mass-screening, the digital platform enables efficient track & trace and has potential to open up the economy New York (March 15, 2021) – Med tech company Pelican […]
Using Smart Sensors and Cloud-based Analytics, Canary’s 20-minute Handheld COVID-19 Saliva-based Molecular Test with PCR Quality Results Achieves CE Mark
Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants under further research and development and not commercially available. Designed for point-of-care (POC) diagnosis, ease of use, rapid and cost-effective mass-screening A mobile-enabled, multiplex platform and connected solution enables efficient real-time reporting of results, […]
Canary Global Approved for Canada’s SR&ED Program for Advancing Science and Technology
Canary Global has been accepted into Canada’s SR&ED program which aims to encourage R&D work conducted for the advancement of scientific knowledge or for the purpose of achieving a technological advancement.Canary applied to be included in the program in order to advance its microRNA (miRNA) work which it began during the COVID epidemic. The company […]
